The main focus of Genelux is oncolytic immunotherapy based on attenuated , genetically engineered oncolytic viruses as therapeutic agent .
Genelux Corporation is a privately held , biopharmaceutical clinical stage company that was founded in 2001 .
The main focus of stage company is oncolytic immunotherapy based on attenuated , genetically engineered oncolytic viruses as therapeutic agent .
Genelux Corporation is a privately held , biopharmaceutical clinical stage company that was founded in 2001 .